Hope for this and many other diseases is fueled by a United Kingdom researcher who is trying to develop delivery systems that bypass these faulty cell membrane proteins to properly orchestrate the ...
Biotech Fluidics offers a range of non-invasive flowmeters for real-time, non-invasive monitoring of liquid flow.
Biotechnology company Nuclera, which enables access to high quality proteins, has launched its nanodisc panel to support screening and scale-up of G-protein coupled receptors (GPCRs). “Since releasing ...
Life science company Amsbio has launched a range of authenticated cell lines covering a range of tumours and tissues. The addition offers over 1,000 independently verified cell lines and versatile ...
Zeiss has unveiled the new Zeiss Crossbeam 750 focused ion beam-scanning electron microscope (FIB-SEM), optimised for demanding sample preparation. It can provide a live, high-resolution “see while ...
Recombinant technology specialist Sino Biological has launched the XPressMAX Cell-Free Protein Synthesis Kit (Cat#: CFKIT02). The solution is designed to supercharge AI-driven high-throughput ...
CDMO partner Freudenberg Medical recently launched CleanAssure, an ISO Class 5 controlled cleanroom for sterile single-use assemblies. The cleaning and sterilisation service supports biopharmaceutical ...
Lundbeck will be presenting its research at the 2026 Alzheimer’s and Parkinson’s Disease conference Lundbeck has shared that new data from a Phase 1b proof-of-mechanism trial of Lu AF28996, a novel ...
A recent study published in Neurology has developed an AI tool to improve diagnostics accuracy in Alzheimer’s disease and related dementias. The results showed that AIDD identified the two diseases ...
AndzonBio2 has signed agreements with the Alborada Drug Discovery Institute (ADDI) at the University of Cambridge and Cambridge Enterprise to advance a new class of therapeutics targeting ...
Servier, an independent international pharmaceutical company governed by a foundation, and n-Lorem Foundation, a non-profit organisation established to provide experimental medicines to patients with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results